These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19683428)

  • 21. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women.
    Suarez L; Pulley L
    J Natl Cancer Inst Monogr; 1995; (18):41-7. PubMed ID: 8562221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological costs of inadequate cervical smear test results.
    French DP; Maissi E; Marteau TM
    Br J Cancer; 2004 Nov; 91(11):1887-92. PubMed ID: 15534608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and validity of the Center for Epidemiologic Studies Depression (CES-D) scale in Serbian women with abnormal Papanicolaou smear results.
    Ilic I; Babic G; Dimitrijevic A; Ilic M; Sipetic Grujicic S
    Int J Gynecol Cancer; 2019 Jul; 29(6):996-1002. PubMed ID: 31203200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptions and concerns of women undergoing Pap smear examination in a tertiary care hospital of India.
    Tiwari A; Kishore J; Tiwari A
    Indian J Cancer; 2011; 48(4):477-82. PubMed ID: 22293264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
    Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
    Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer screening among Taiwanese women: a transtheoretical approach.
    Tung WC; Lu M; Cook D
    Oncol Nurs Forum; 2010 Jul; 37(4):E288-94. PubMed ID: 20591792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
    Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
    Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial.
    Gray NM; Sharp L; Cotton SC; Avis M; Philips Z; Russell I; Walker LG; Whynes D; Little J;
    Qual Life Res; 2005 Aug; 14(6):1553-62. PubMed ID: 16110935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Perceived barriers to taking a Pap smear: predictors in immigrant women].
    Wu SJ; Tsai SH; Tseng HF; Huang YY; Wang YH; Lin SY
    Hu Li Za Zhi; 2010 Oct; 57(5):36-46. PubMed ID: 20878609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency of having pap-smear tests among women between 15-64 years old and the evaluation of the level of their knowledge.
    Sevil S; Kevser O; Aleattin U; Ozlem D
    J Pak Med Assoc; 2013 Jul; 63(7):873-7. PubMed ID: 23901712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
    Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological response to cervical screening.
    Bell S; Porter M; Kitchener H; Fraser C; Fisher P; Mann E
    Prev Med; 1995 Nov; 24(6):610-6. PubMed ID: 8610085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
    Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
    Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knowledge and attitudes regarding cervical cancer screening among women with physical disabilities living in the community.
    Wu LW; Lin LP; Chen SF; Hsu SW; Loh CH; Wu CL; Lin JD
    Res Dev Disabil; 2012; 33(2):376-81. PubMed ID: 22119684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.